Stay updated on IPATHER: PI3KCA-mutant Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the IPATHER: PI3KCA-mutant Breast Cancer Clinical Trial page.

Latest updates to the IPATHER: PI3KCA-mutant Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a Phase Ib study of ipatasertib in combination with pertuzumab and trastuzumab for metastatic breast cancer, and the addition of references to metastatic breast cancer and a new revision number.SummaryDifference35%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check86 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
Stay in the know with updates to IPATHER: PI3KCA-mutant Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IPATHER: PI3KCA-mutant Breast Cancer Clinical Trial page.